| Literature DB >> 35883708 |
Mithun Rudrapal1, Siddhartha Maji2, Shiv Kumar Prajapati2, Payal Kesharwani2, Prashanta Kumar Deb3, Johra Khan4,5, Randa Mohamed Ismail4,6, Rani S Kankate7, Ranjan Kumar Sahoo8, Shubham J Khairnar9, Atul R Bendale10.
Abstract
Cigarette smoking has been responsible for causing many life-threatening diseases such as pulmonary and cardiovascular diseases as well as lung cancer. One of the prominent health implications of cigarette smoking is the oxidative damage of cellular constituents, including proteins, lipids, and DNA. The oxidative damage is caused by reactive oxygen species (ROS, oxidants) present in the aqueous extract of cigarette smoke (CS). In recent years, there has been considerable interest in the potential health benefits of dietary polyphenols as natural antioxidant molecules. Epidemiological studies strongly suggest that long-term consumption of diets (fruits, vegetables, tea, and coffee) rich in polyphenols offer protective effects against the development of cancer, cardiovascular diseases, diabetes, osteoporosis, and neurodegenerative diseases. For instance, green tea has chemopreventive effects against CI-induced lung cancer. Tea might prevent CS-induced oxidative damages in diseases because tea polyphenols, such as catechin, EGCG, etc., have strong antioxidant properties. Moreover, apple polyphenols, including catechin and quercetin, provide protection against CS-induced acute lung injury such as chronic obstructive pulmonary disease (COPD). In CS-induced health problems, the antioxidant action is often accompanied by the anti-inflammatory effect of polyphenols. In this narrative review, the CS-induced oxidative damages and the associated health implications/pathological conditions (or diseases) and the role of diets rich in polyphenols and/or dietary polyphenolic compounds against various serious/chronic conditions of human health have been delineated.Entities:
Keywords: COPD; bioavailability; cardioprotective; cigarette smoke; dietary polyphenols; oxidative damage
Year: 2022 PMID: 35883708 PMCID: PMC9311530 DOI: 10.3390/antiox11071217
Source DB: PubMed Journal: Antioxidants (Basel) ISSN: 2076-3921
Figure 1Consequences of increased oxidative stress in COPD patients. Cigarette smoking induces the formation of ROS, and thereby increases incidences of COPD and related diseases.
Classification of polyphenolic compounds and their main dietary sources with examples [84,85,86,87,88,89].
| Class of Polyphenols | Subclass | Prototype Compounds | Major Dietary Sources |
|---|---|---|---|
| Flavonoids | Flavone | Baicalein, apigenin, luteolin, chrysin | Herbal tea, fenugreek, onion, garlic, black pepper, citrus fruits, green leafy vegetables |
| Isoflavone | Genistein, daidzein, biochanin A, glycitein | Chickpea, peanut, dairy products, eggs, meat, seafood, soy products, legumes | |
| Flavonol | Rutin, quercetin, myricetin, fisetin | Tea, chocolate, cocoa, onions, scallions, kale, broccoli, apples, berries, | |
| Flavanonol | Taxifolin, aromadendrin, engeletin | Milk thistle seeds, citrus fruits | |
| Flavanol | (−)- epicatechin, (+)-catechin, (−)-epigallocatechin gallate (EGCG), theaflavins | Cocoa, chocolate, tea, grapes, apples | |
| Chalcone | Butein, xanthoangelol, 4-hydroxyderricin, cardamomin, isoliquiritigenin, isosalipurposide | Tomatoes, liquorice, shallots, bean sprouts | |
| Flavanone | Hesperidin, hesperetin, naringin, naringenin, eriodictyol | Pomegranate, citrus fruits, tomatoes, grape fruit | |
| Dihydrochalcones | Phlorizin, aspalathin, nothofagin | Apples and apple products, rooibos tea | |
| Anthocyanidins | Cyanidin, peonidin, delphinidin, petunidin, pelargonidin, malvidin | Red wines, cherries, red grapes, berries, flowers, oranges, black soybeans, hibiscus sp., purple/black rice, onions, red potatoes, purple cabbage | |
| Proanthocyanidins | Procyanidin B1, procyanidin B2, procyanidin B3 | Berries, cherries, red grapes, red wines, flowers, oranges, black soybeans, banana, cocoa, and apricot, cereals such as sorghum and barley | |
| Non-flavonoids | Phenolic acids | Caffeic acid, sinapic acid, gallic acid, protocatechuic acid, ferulic acid, | Green tea, citrus fruits, kiwi, coffee, berries, apples, rice bran, passion fruit, cherries, mangoes, wheat, corn flours |
| Stilbenes | Resveratrol | grapes (skin), mulberries, peanuts, red wine | |
| Lignans | Silymarin, sylibin, sesamin, syringaresinol, ecoisolariciresinol, matairesinol, medioresinol, pinoresinol, lariciresino | Flaxseed, soybeans, broccoli, cabbage, milk thistle, apricots, strawberries, etc. | |
| Coumarins | Dicumarol, osthole | Cinnamon, green tea, carrot, bison grass |
Figure 2Structures of prototype polyphenols.
Figure 3Possible mechanism of action of polyphenols in oxidative stress induced diseases.
Figure 4Bioavailability issues of polyphenols and strategies to overcome it.
Bioavailability issues of polyphenols and various pharmaceutical formulations/delivery systems to overcome it.
| Polyphenol | Bioavailability Issue | Delivery System | Subject | Result | Reference |
|---|---|---|---|---|---|
| Curcumin | Low bioavailability and degradation in solution form | Microencapsulation of curcumin in liposomes by the combination of ethanol injection and high-pressure processing | - | Effectively decreases the size of particle and PDI, which helps to cross the biological membrane. Sterilizes the bacterial, which prevent degradation in solution | [ |
| Low bioavailability and rapid metabolism | Nanoparticle fabricated by EGCG and PVP | - | Bioavailability increased 12-fold through intestine | [ | |
| Low bioavailability and rapid metabolism | Emulsion was formed using different types of oils: corn oil, olive oil, and medium chain triglycerides (MCT) | - | Type of oil increased its transenterocyte absorption and reduced cellular metabolism | [ | |
| Less physicochemical properties and oral bioavailability | Microencapsulating turmeric oleoresin with bioenhancers by spray drying using piperine and quercetin | - | Spray-dried powder with piperine (PIP) and quercetin (Quer) has higher permeability | [ | |
| Low solubility and bioavailability | Zein-based nanoparticles | Wistar rats | Incresaed (9-fold) oral bioavailability with respect to the standard curcumin natural extract. | [ | |
| Low bioavailability | Curcugen: dispersible, 98.5% turmeric-based curcuminoids formula | Randomized double-blind, 2-way cross over, single oral dose in humans | Auc-39 times and Cmax 16.1 times higher than of curcumin | [ | |
| Low bioavailability | Curcumin-encapsulated chitosan (Cur-CS) nanoparticles | Crandell–Rees feline kidney of cat | Enhanced bioavailability, Cmax- 621.5 ng/mL three times more than normal curcumin | [ | |
| Low bioavailability | Curcumin-loaded self-microemulsifying lipid carriers | Male Wistar rats | Higher bioavailability (29-fold) as compared to curcumin suspension | [ | |
| Quercetin | Low bioavailability and less efficacy | Quercetin nano emulsion | Streptozocin-induced antidiabetic study in rats | Cmax of quercetin NE is 5962.74 ± 238.54 ng/mL and of quercetin pure drug is 1634.28 ± 70.18 ng/mL. AUC0-t and AUC0−∞ were 4.46 and 5.32 times higher than pure drug, respectively | [ |
| Green tea (Epigallocatechin-3-gallate and L-theanine) | EGCG bioavailability is <5% | Preparation of | Rats | EGCG bioavailability is improved through lipid lowerig and weight loss effects of EGCG ( | [ |
| Low permeation and poor stability leads to low oral bioavailability | Nanospanlastic | Male Wistar rats | Cmax- niosomal formula ( | [ | |
| Low bioavailability and chemical instability | EGCG loaded solid lipid nanoparticles SLN | Male Wistar albino rats | Cmax of EGCG is 60.7 ± 1.07 * and EGCG loaded SLN 240 ± 16 * | [ | |
| Poor oral bioavailability | Nanoparticles (NP) | Sprague Dawley rats | Cmax- EGCG NP 653.5 ± 181.3 * and EGCG powder 564.5 ± 121.7 * | [ | |
| Poor bioaccesibility | Nanoemulsion | Sprague-Dawley (SD) rats | Cmax- nanoemulsion 166.7 ± 22.6 * and sol 258.8 ± 135.1 * | [ | |
| Green tea (Catechin) | Poor oral bioavailability | Catechin-loaded chitosan-tethered liposomes (Chitosomes) | Male Wistar rats | Cmax- Chitosomes 239.0 ± 35.27 * and sol 120.0 ± 3.97 * | [ |
| Flaxseed | Poor efficacy | Flaxseed oil-based neuronanoemulsions (NNEs) | Balb/c mice | Plasma | [ |
| Gallic, quercetin, amla, pomegranate | Poor bioavailability | Polyherbal nanoparticles and polyherbal extract following oral administration, pharmacokinetic parameters for polyherbal nanop | Male Wistar rats | GA and quercetin in polymeric nanoparticles improve their oral bioavailability | [ |
* Cmax—maximum plasma concentration (ng/mL), ** AUC—area under the curve (ng·h/mL). EGCG—epigallocatechin-3-gallate, PVP- poly (N-vinylpyrrolidone).